Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Insights into extracellular vesicle-based platforms on the way to cancer treatment

Bagheri E., Aminyazdi E., Ramezani M., Mohammadi M., Abnous K., Taghdisi SM.

Narrative Review on Face & Skin, Hip, published in J Transl Med (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Transl Med (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41437080
PMCID
PMC12837121
DOI
10.1186/s12967-025-07554-4

Abstract (original English)

BACKGROUND: Exosomes are nanoscale extracellular vesicles (EVs) (≈30–150 nm) defined by a lipid bilayer that encloses an aqueous interior. This amphiphilic architecture permits the simultaneous encapsulation of hydrophobic, hydrophilic, and amphipathic compounds. Their endogenous biogenesis results in high biocompatibility, negligible immunogenicity, and the capacity to evade rapid clearance while crossing biological barriers. Additionally, the Surface antigens retained from the cell of origin provide exosomes with innate specificity, enabling efficient uptake by specific cell subpopulations. Studies have successfully engineered exosomes to transport inorganic nanoparticles, chemotherapeutic drugs, nucleic acids, and contrast agents, resulting in enhanced therapeutic efficacy and diagnostic sensitivity. Hybrid exosome systems, which integrate exosomes with supplementary carriers such as polymers, lipids, and nanoparticles, have been developed to further enhance their efficacy and expand the translational potential of exosome-based nanomedicine. METHODS: A comprehensive literature search was conducted across PubMed, Scopus, and Google Scholar to identify relevant studies focusing on the therapeutic and diagnostic applications of exosomes in cancer, including engineered and hybrid exosome systems. It was extended to include the most recent publications up to and including those r

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansNeoplasmsExosomesExtracellular Vesicles

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research